接受奥沙利铂联合化疗的转移性结直肠癌患者癌胚抗原激增：对肿瘤标志物监测及指南的启示 - Suppr

Suppr

超能文献

Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines.

作者信息

Sørbye Halfdan, Dahl Olav

出版信息

J Clin Oncol. 2003 Dec 1;21(23):4466-7. doi: 10.1200/JCO.2003.99.200.

DOI:10.1200/JCO.2003.99.200

PMID:14645446

Abstract

摘要

相似文献

Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines.接受奥沙利铂联合化疗的转移性结直肠癌患者癌胚抗原激增：对肿瘤标志物监测及指南的启示

J Clin Oncol. 2003 Dec 1;21(23):4466-7. doi: 10.1200/JCO.2003.99.200.

[A case of local recurrence of colon cancer responding to chemotherapy with low-dose oxaliplatin, 5-FU and l-LV].[一例对低剂量奥沙利铂、5-氟尿嘧啶和左亚叶酸钙化疗有反应的结肠癌局部复发病例]

Gan To Kagaku Ryoho. 2007 Aug;34(8):1291-3.

[FOLFOX].[氟尿嘧啶/亚叶酸钙/奥沙利铂方案]

Gan To Kagaku Ryoho. 2006 Jul;33(7):911-4.

Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.奥沙利铂联合每周大剂量推注氟尿嘧啶和高剂量亚叶酸钙（ROX）作为结直肠癌患者一线治疗的I/II期研究。

Jpn J Clin Oncol. 2006 Apr;36(4):218-23. doi: 10.1093/jjco/hyl020.

[A case of metastatic colon cancer to paraaortic lymph nodes and liver treated successfully with oxaliplatin combination chemotherapy].[1例经奥沙利铂联合化疗成功治疗的主动脉旁淋巴结及肝转移结肠癌]

Gan To Kagaku Ryoho. 2007 Jul;34(7):1135-7.

Oxaliplatin in the treatment of colorectal cancer.奥沙利铂在结直肠癌治疗中的应用。

Expert Opin Drug Metab Toxicol. 2007 Apr;3(2):281-94. doi: 10.1517/17425255.3.2.281.

Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.一项III期试验，比较4天时间调制疗法与氟尿嘧啶、亚叶酸钙和奥沙利铂的2天传统给药方案作为转移性结直肠癌一线化疗的疗效：欧洲癌症研究与治疗组织时间疗法组。

J Clin Oncol. 2006 Aug 1;24(22):3562-9. doi: 10.1200/JCO.2006.06.1440.

Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.奥沙利铂联合5-氟尿嘧啶/亚叶酸钙（FOLFOX-4）用于经治结直肠癌患者的挽救性化疗。

Gan To Kagaku Ryoho. 2007 Jul;34(7):1079-84.

Update: NCCN colon and rectal cancer clinical practice guidelines.更新：美国国立综合癌症网络（NCCN）结肠癌和直肠癌临床实践指南。

J Natl Compr Canc Netw. 2004 Sep;2 Suppl 3:S-14-8.

Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.ERCC1、胸苷酸合成酶和谷胱甘肽S-转移酶π在晚期结直肠癌5-氟尿嘧啶/奥沙利铂化疗中的预后价值

Am J Clin Oncol. 2009 Feb;32(1):38-43. doi: 10.1097/COC.0b013e31817be58e.

引用本文的文献

Cytoreductive single-fraction stereotactic radiation therapy prior to living donor transplantation for inoperable liver-confined metastatic rectal cancer.在活体供体移植前，对无法手术切除的局限于肝脏的转移性直肠癌进行减瘤单次立体定向放射治疗。

J Radiosurg SBRT. 2024;9(2):181-183.

Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.采用仅血浆循环肿瘤 DNA 检测预测有治愈意图治疗后转移性结直肠癌复发的微小残留病灶。

Clin Cancer Res. 2024 Jul 15;30(14):2964-2973. doi: 10.1158/1078-0432.CCR-23-3660.

Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.评估甲基化循环肿瘤DNA联合病理预后因素在预测结直肠癌复发中的作用。

Biomark Insights. 2024 Feb 28;19:11772719241232870. doi: 10.1177/11772719241232870. eCollection 2024.

Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection.基于全面基因组分析（CGP）的个体化分子残留病灶（MRD）检测：一项探索性分析，来自转移性结直肠癌（mCRC）患者接受手术切除的 PREDATOR 研究。

Int J Mol Sci. 2022 Sep 29;23(19):11529. doi: 10.3390/ijms231911529.

Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.循环肿瘤 DNA 在精准肿瘤学中的应用及其在结直肠癌中的应用。

Int J Mol Sci. 2022 Apr 18;23(8):4441. doi: 10.3390/ijms23084441.

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management.循环肿瘤DNA作为个性化结直肠癌患者管理的预后和预测标志物的临床有效性

Cancers (Basel). 2022 Feb 8;14(3):851. doi: 10.3390/cancers14030851.

Longitudinal High-Throughput Sequencing of the T-Cell Receptor Repertoire Reveals Dynamic Change and Prognostic Significance of Peripheral Blood TCR Diversity in Metastatic Colorectal Cancer During Chemotherapy.纵向高通量测序 T 细胞受体库揭示转移性结直肠癌化疗期间外周血 TCR 多样性的动态变化及预后意义。

Front Immunol. 2022 Jan 12;12:743448. doi: 10.3389/fimmu.2021.743448. eCollection 2021.

Unusual increase in carcinoembryonic antigen despite response to selpercatinib in two patients with medullary thyroid cancer.两名甲状腺髓样癌患者在接受塞尔帕替尼治疗有反应的情况下，癌胚抗原却出现异常升高。

Eur Thyroid J. 2022 Feb 4;11(2):e210104. doi: 10.1530/ETJ-21-0104.

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.使用基于个体化循环肿瘤 DNA 分析的方法检测结直肠癌转移灶切除术后患者的分子残留病灶。

JCO Precis Oncol. 2021 Jul 21;5. doi: 10.1200/PO.21.00101. eCollection 2021 Jul.

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response.转移性结直肠癌患者循环肿瘤DNA的连续监测以预测治疗反应

Front Genet. 2019 May 21;10:470. doi: 10.3389/fgene.2019.00470. eCollection 2019.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验